humans (10)
female (9)
uterine neoplasms (4)
aged (3)
animals (3)
cell line, tumor (3)
cystadenocarcinoma, serous (3)
middle aged (3)
molecular targeted therapy (3)
ovarian neoplasms (3)
receptor, erbb-2 (3)
adult (2)
antibodies, monoclonal (2)
antibodies, monoclonal, humanized (2)
antineoplastic agents (2)
endometrial neoplasms (2)
ferric compounds (2)
obstetrics and gynecology (2)
oncogene proteins, viral (2)
repressor proteins (2)
t-lymphocytes, cytotoxic (2)
uterine cervical neoplasms (2)
aged, 80 and over (1)
antibodies, monoclonal, murine-derived (1)
antineoplastic combined chemotherapy protocols (1)
article (1)
breast neoplasms (1)
cancer vaccines (1)
capsid proteins (1)
carcinoma (1)
carcinosarcoma (1)
cell division (1)
chitosan (1)
class i phosphatidylinositol 3-kinases (1)
claudin-3 (1)
claudin-4 (1)
clone cells (1)
coated materials, biocompatible (1)
cobalt (1)
combination (1)
contrast media (1)
cyclin e (1)
cystadenocarcinoma, papillary (1)
dendritic cells (1)
drug resistance, neoplasm (1)
efficacy (1)
enterotoxins (1)
epitopes, t-lymphocyte (1)
epothilones (1)
exome (1)